Gardnerella Vaginalis

See also the genus page: gardnerella

Gardnerella vaginalis is the primary causative agent of bacterial vaginosis (BV), the most common vaginal infection worldwide. This species page focuses on the species-level biology — particularly the vaginolysin cytotoxin and biofilm architecture — that distinguish G. vaginalis from the broader genus.

Vaginolysin — An Iron-Regulated Toxin

Vaginolysin (VLY) is a cholesterol-dependent cytolysin (CDC) that is G. vaginalis's primary virulence factor:

  • VLY forms pores in human vaginal epithelial cells by binding to the cholesterol-rich membrane complement regulatory molecule CD59.
  • VLY expression is iron-regulated — iron availability modulates vaginolysin production, connecting Gardnerella virulence to the mucosal iron landscape controlled by lactoferrin roberts 2019 mucosal lactoferrin genital infections iron.
  • Statin repurposing: Because VLY requires membrane cholesterol for binding, statins (which deplete membrane cholesterol) can reduce vaginolysin cytotoxicity. Simvastatin at sub-antimicrobial doses significantly reduces G. vaginalis biofilm virulence in vitro abdelmaksoud 2017 statins vaginal microbiome gardnerella vaginolysin. This is a Cureva-relevant drug repurposing lead.

Biofilm Architecture

G. vaginalis initiates the polymicrobial biofilm that defines BV:

  1. G. vaginalis adheres to vaginal epithelial cells and forms the initial biofilm scaffold.
  2. atopobium (A. vaginae) embeds within the Gardnerella biofilm, becoming protected from metronidazole.
  3. sneathia, megasphaera, and prevotella colonize the biofilm surface.

This biofilm architecture explains BV recurrence: metronidazole kills planktonic bacteria but the biofilm persists, enabling rapid recolonization.

Disease Associations

Cross-References